{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:14:49Z","timestamp":1790896489450,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.drugpo.2017.05.012","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T14:35:03Z","timestamp":1496241303000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Drug use practices among people who inject drugs in a context of drug market changes: Challenges for optimal coverage of harm reduction programs"],"prefix":"10.1016","volume":"45","author":[{"given":"\u00c9lise","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Morissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caty","family":"Blanchette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-9874","authenticated-orcid":false,"given":"Karine","family":"Blouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Alary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2017.05.012_bib0005","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.12.035","article-title":"Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients","volume":"89","author":"Bluthenthal","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/1606635021000021322","article-title":"Crack and the political economy of social suffering","volume":"11","author":"Bourgois","year":"2003","journal-title":"Addiction Research & Theory"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0015","series-title":"In search of respect: Selling crack in El Barrio","author":"Bourgois","year":"2003"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0020","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1360-0443.2012.03803.x","article-title":"The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users","volume":"107","author":"Bruneau","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.drugpo.2008.08.003","article-title":"Heroin in brown, black and white: Structural factors and medical consequences in the US heroin market","volume":"20","author":"Ciccarone","year":"2009","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"The New England Journal of Medecine"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0035","series-title":"Community outbreak of HIV infection linked to injection drug use of oxymorphone\u2014Indiana, 2015","author":"Conrad","year":"2015"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: A review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1472-6963-14-90","article-title":"Trends and changes in prescription opioid analgesic dispensing in Canada","volume":"14","author":"Fischer","year":"2014","journal-title":"BMC Health Services Research"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0050","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.17269\/cjph.105.4143","article-title":"Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: An update 5 years later","volume":"105","author":"Fischer","year":"2014","journal-title":"Canadian Journal of Public Health"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0055","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/pds.3404","article-title":"High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005\u20132009","volume":"22","author":"Fischer","year":"2013","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0060","first-page":"31","article-title":"The spread of intravenous drug use and AIDS in a neighborhood in Spain","volume":"8","author":"Gamella","year":"1994","journal-title":"Medical Anthropology"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0065","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1360-0443.1995.tb01068.x","article-title":"Self-reports of HIV risk behavior by injecting drug users: Are they reliable?","volume":"90","author":"Goldstein","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0070","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00126334-200208150-00007","article-title":"Continuing HIV transmission among injection drug users in Eastern Central Canada: The SurvUDI Study, 1995 to 2000","volume":"30","author":"Hankins","year":"2002","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugpo.2014.09.009","article-title":"It\u2019s Russian roulette: Adulteration, adverse effects and drug use transitions during the 2010\/2011 United Kingdom heroin shortage","volume":"26","author":"Harris","year":"2015","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0080","series-title":"General additive models","author":"Hastie","year":"1990"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0085","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/02791072.2006.10399856","article-title":"Changing patterns of cocaine and HIV risks in the south of Brazil","volume":"38","author":"Inciardi","year":"2006","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0090","series-title":"Global report: UNAIDS report on the global AIDS epidemic 2012","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2012"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2013.01.007","article-title":"Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers\u2014United States, 2002\u20132004 and 2008\u20132010","volume":"132","author":"Jones","year":"2013","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0100","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2013.272","article-title":"Pharmaceutical overdose deaths, United States","volume":"309","author":"Jones","year":"2010","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0105","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/QAD.0000000000000948","article-title":"Sex work and HIV incidence among people who inject drugs","volume":"30","author":"Kerr","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0110","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.2105\/AJPH.2014.301966","article-title":"Determinants of increased opioid-related mortality in the United States and Canada, 1990\u20132013: A systematic review","volume":"104","author":"King","year":"2014","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annual Review of Public Health"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0120","first-page":"35","article-title":"Associations between prescription opioid injection and Hepatitis C virus among young injection drug users","volume":"22","author":"Lankenau","year":"2015","journal-title":"Drugs (Abingdon England)"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0125","series-title":"Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection\u2014\u00c9pid\u00e9miologie du VIH de 1995 \u00e0\u2014\u00c9pid\u00e9miologie du VHC de 2003 \u00e0 2014","author":"Leclerc","year":"2015"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.drugpo.2007.02.008","article-title":"I inject less as I have easier access to pipes: Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed","volume":"19","author":"Leonard","year":"2008","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0135","first-page":"40","article-title":"Heroin and cocaine co-use in a group of injection drug users in Montr\u00e9al","volume":"29","author":"Leri","year":"2004","journal-title":"Journal of Psychiatry & Neuroscience"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0145","series-title":"Substance abuse and mental health services administration","article-title":"The NSDUH report: trends in heroin use in the United States: 2002 to 2013","author":"Lipari","year":"2015"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","article-title":"Every \u2018never\u2019 I ever said said came true: Transitions from opioid pills to heroin injecting","volume":"25","author":"Mars","year":"2014","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0155","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0160","first-page":"298","article-title":"Trends of HIV infection among injection drug users in Brazil in the 1990: The impact of changes in patterns of drug use","volume":"28","author":"Mesquita","year":"2001","journal-title":"JAIDS"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0165","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/aje\/kwf086","article-title":"Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988\u20131998","volume":"156","author":"Nelson","year":"2002","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0170","first-page":"889","article-title":"Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection","volume":"165","author":"Patrick","year":"2001","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0175","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/dta.1625","article-title":"Changes in patterns of injecting drug use in Hungary: A shift to synthetic cathinones","volume":"6","author":"P\u00e9terfi","year":"2014","journal-title":"Drug Testing and Analysis"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/00952991003592311","article-title":"Risk practices associated with bacterial infections among injection drug users in Denver, Colorado","volume":"36","author":"Phillips","year":"2010","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0185","series-title":"Summary of key findings from I-track phase 3 (2010\u20132012)","author":"Public Health Agency of Canada","year":"2014"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0190","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.socscimed.2004.12.024","article-title":"The social structural production of HIV risk among injecting drug users","volume":"61","author":"Rhodes","year":"2005","journal-title":"Social Science and Medicine"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0195","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3109\/10826084.2014.997825","article-title":"Exploration of a crack use setting and its impact on drug users' risky drug use and sexual behaviors: The case of piaules in a Montr\u00e9al neighborhood","volume":"50","author":"Roy","year":"2015","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0200","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3109\/10826084.2011.552932","article-title":"The growing popularity of prescription opioid injection in downtown Montr\u00e9al: New challenges for harm reduction","volume":"46","author":"Roy","year":"2011","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1465-3362.2011.00299.x","article-title":"Drug use patterns in the presence of crack in downtown Montr\u00e9al","volume":"31","author":"Roy","year":"2012","journal-title":"Drug & Alcohol Review"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0210","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0215","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995\u20132009","volume":"103","author":"Schwartz","year":"2013","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0220","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/01459740.2000.9966166","article-title":"Fluctuating drug markets and HIV risk taking: Female drug users and their relationship with drug markets","volume":"18","author":"Sterk","year":"2000","journal-title":"Medical Anthropology"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0230","series-title":"The global diffusion of injecting drug use: implications for human immunodeficiency virus infection","author":"Stimson","year":"1993"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0235","series-title":"Drug injecting and HIV infection: Global dimensions and local responses","first-page":"1","article-title":"Global perspectives on drug injecting","author":"Stimson","year":"1998"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0240","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1086\/317607","article-title":"Hepatitis C virus infection: Prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997\u20131999","volume":"182","author":"Thorpe","year":"2000","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0245","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0376-8716(03)00013-9","article-title":"Changes in patterns of drug injection concurrent with a sustainedreduction in the availability of heroin in Australia","volume":"70","author":"Topp","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0250","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200304110-00014","article-title":"Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic","volume":"17","author":"Tyndall","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0255","series-title":"World drug report 2015. United Nations publication, sales no. E.15. XI.6","author":"United Nations Office on Drugs and Crime","year":"2015"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0260","series-title":"Drug situation in Vancouver","author":"Urban Health Research Initiative (UHRI)","year":"2013"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0265","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/jech.55.5.356","article-title":"Large decline in injecting drug use in Amsterdam, 1986\u20131998: Explanatory mechanisms and determinants of injecting transitions","volume":"55","author":"van Ameijden","year":"2001","journal-title":"Journal of Epidemiology & Community Health"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0270","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1360-0443.2012.03932.x","article-title":"Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings","volume":"107","author":"Vickerman","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0275","doi-asserted-by":"crossref","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0280","first-page":"154","article-title":"Sexual behavior and risks for HIV infection and transmission among male injecting drug users in Yunnan, China","volume":"13","author":"Yao","year":"2009","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.05.012_bib0285","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.2105\/AJPH.2014.302142","article-title":"Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics","volume":"104","author":"Zibbell","year":"2014","journal-title":"American Journal of Public Health"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T10:52:27Z","timestamp":1538045547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917301160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":57,"alternative-id":["S0955395917301160"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.012","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug use practices among people who inject drugs in a context of drug market changes: Challenges for optimal coverage of harm reduction programs","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}